ENG
History
- 04
-
Drone Treg Selected for Government-initiated Drug Development Program (Korean Fund for Regenerative Medicine)
T.O.P. NK Phase 1 IND Approval (Korea)
- 12
-
Permission for Management Business of Human Body Cells
Research license and option agreement with Optieum Biotechnologies
- 11
- Presented preclinical data of T.O.P. NK at SITC 2022
- 08
-
Partnership with HK Inno.N to research and develop CAR-NK
Partnership with Cartexell(a subsidiary of Helixmith) to research and develop CAR-NK
- 06
- ISO27001(Information Security Management System) certified
- 03
-
MOU with Yonsei University health system & GI-Innovation
Korea Intellectual Property Office(KIPO) certified excellent intellectual property managing company(IPCERT)
- 02
- Succeed 200L cultivation for T.O.P. NK (Feeder-free)
- 01
-
Patent registration of Nano Block Co-polymer Unit Material (Korea)
Patent registration of methods and compositions for T.O.P. NK (Korea)
- 12
- Permission for Manufacturing Advanced Biological Products
- 09
- Strategic investment(20 million USD)
- 06
-
Completion of GMP facility
Series B financing(48 million USD)
- 05
- MOU with Ewha University Medical Center
- 03
-
Korea Intellectual Property Office(KIPO) certified excellence company in employee invention promotion
- 01
-
MOU with International Vaccine Institute(IVI)
MOU with Severance hospital
MOU with GI-BIOME
- 12
- Awardee of ‘Cytiva Korea CEO award’ at the 2020 Bio Challenge
- 10
- Success in Scale-up to 50L of T.O.P. NK
- 07
- Research Collaboration with Miltenyi Biotec Inc.
- 06
- Series A financing(26 million USD)
- 04
- Nano NK research on the cover of Advanced Material Journal (IF=30.85)
- 07
- Non-exclusive agreement of GI-101
- 05
- Registration of our affiliate R&D center
- 02
- Accreditation as a bio-venture
- 01
- In-licensing of Nano NK cell
- 10
-
In-licensing for Drone Treg cell
Foundation of GI-Cell
